Neuren Pharmaceuticals Limited (ASX:NEU)
Australia
· Delayed Price · Currency is AUD 11.93
-0.27 (-2.21%)
Apr 28, 2026, 4:10 PM AEST
Neuren Pharmaceuticals Market Cap
Neuren Pharmaceuticals has a market cap or net worth of 1.51 billion as of April 28, 2026. Its market cap has increased by 25.56% in one year.
Market Cap
1.51B
Enterprise Value
1.21B
Revenue
64.65M
Ranking
n/a
PE Ratio
51.27
Stock Price
11.93
Market Cap Chart
Since February 3, 2005, Neuren Pharmaceuticals's market cap has increased from 20.93M to 1.51B, an increase of 7,108.83%. That is a compound annual growth rate of 22.31%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PYC Therapeutics | 1.27B |
| Clarity Pharmaceuticals | 1.09B |
| Mesoblast | 2.84B |
| Opthea | 738.77M |
| Racura Oncology | 517.08M |
| Telix Pharmaceuticals | 5.05B |
| Clinuvel Pharmaceuticals | 455.87M |
| Starpharma Holdings | 303.23M |